Skip to main content

Table 1 DAPT and PARIS scores (modified from [6, 7])

From: Practical issues in clinical scenarios involving CKD patients requiring antithrombotic therapy in light of the 2017 ESC guideline recommendations

DAPT score

PARIS scores

Major bleeding

Thrombosis/MI

Parameter

Score

Parameter

Score

Parameter

Score

Age, years

Age, years

Diabetes mellitus

 ≥75

–2

 <50

0

 None

0

 65 to <75

–1

 50–59

+ 1

 Non-insulin dependent

+ 1

 <65

0

 60–69

+ 2

 Insulin dependent

+ 3

Current cigarette smoking

1

 70–79

+ 3

Acute coronary syndrome

Diabetes mellitus

1

 ≥80

+ 4

 No

0

MI at presentation

1

Body mass index, kg/m2

 Yes, Tn negative

+ 1

Prior PCI or prior MI

1

 <25

+ 2

 Yes, Tn positive

+ 2

Paclitaxel-eluting stent

1

 25–34.9

0

Current smoking

Stent diameter <3 mm

1

 ≥35

+ 2

 Yes

+ 1

CHF or LVEF < 30%

2

Current smoking

 No

0

Vein graft PCI

2

 Yes

+ 2

eGFR < 60 mL/min

  

 No

0

 Present

+ 2

  

Anemia

 Absent

0

  

 Present

+ 3

Prior PCI

  

 Absent

0

 Yes

+ 2

  

eGFR < 60 mL/min

 No

0

  

 Present

+ 2

Prior CABG

  

 Absent

0

 Yes

+ 2

  

Triple therapy on discharge

 No

0

  

 Yes

+ 2

  
  

 No

0

  
  1. CHF cardiac heart failure, eGFR estimated glomerular filtration rate, LVEF left ventricular ejection fraction, MI myocardial infarction, PCI percutaneous coronary intervention, Tn troponin